Terms: = Breast cancer AND PTK6, BRK, 5753, ENSG00000101213, Q13882, FLJ42088 AND Prognosis
6 results:
1. MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative breast cancer Metastases.
Ito K; Harada I; Martinez C; Sato K; Lee E; Port E; Byerly JH; Nayak A; Tripathi E; Zhu J; Irie HY
Cancer Res Commun; 2024 Mar; 4(3):946-957. PubMed ID: 38457262
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic impact of ptk6 expression in triple negative breast cancer.
Chen Y; Qu W; Tu J; Yang L; Gui X
BMC Womens Health; 2023 Nov; 23(1):575. PubMed ID: 37932734
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Analysis Reveals ptk6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in breast cancer.
Wang L; Luo S; Wang Z; Huang Y; Luo Y; Xie X
J Immunol Res; 2022; 2022():5160705. PubMed ID: 36405012
[TBL] [Abstract] [Full Text] [Related]
4. breast Tumour Kinase (brk/ptk6) Contributes to breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro.
Burmi RS; Box GM; Wazir U; Hussain HA; Davies JA; Court WJ; Eccles SA; Jiang WG; Mokbel K; Harvey AJ
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327957
[TBL] [Abstract] [Full Text] [Related]
5. Low expression of ptk6/brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
Liu XK; Zhang XR; Zhong Q; Li MZ; Liu ZM; Lin ZR; Wu D; Zeng MS
J Transl Med; 2013 Mar; 11():59. PubMed ID: 23497344
[TBL] [Abstract] [Full Text] [Related]
6. Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.
Zhao C; Yasui K; Lee CJ; Kurioka H; Hosokawa Y; Oka T; Inazawa J
Cancer; 2003 Jul; 98(1):18-23. PubMed ID: 12833450
[TBL] [Abstract] [Full Text] [Related]
